However, these federal programs typically don’t cover weight loss medications. Coverage and eligibility vary by state so check with your local representative for coverage details. Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist marketed by Novo Nordisk with the brand name drugs Wegovy, Ozempic, and Rybelsus. Wegovy is FDA-approved for chronic weight management in obese […]